1. Long COVID after breakthrough SARS-CoV-2 infection;Al-Aly;Nat. Med.,2022
2. Anti-SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients;Alexopoulos;Neurol. Neuroimmunol. Neuroinflamm.,2020
3. Astrocyte glypicans 4 and 6 promote formation of excitatory synapses via GluA1 AMPA receptors;Allen;Nature,2012
4. Tropism of SARS-CoV-2 for human cortical astrocytes;Andrews;Proc. Natl. Acad. Sci. USA,2022
5. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study;Antonelli;Lancet Infect. Dis.,2022